Recruiting Thrombocytopenia Studies in Greenville
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP...
About Thrombocytopenia Clinical Trials in Greenville
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 2 thrombocytopenia clinical trials recruiting participants in Greenville, NORTH%20CAROLINA. These studies are seeking a combined 211 participants. Research is being sponsored by Takeda, Kedrion S.p.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Greenville — FAQ
Are there thrombocytopenia clinical trials in Greenville?
Yes, there are 2 thrombocytopenia clinical trials currently recruiting in Greenville, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Greenville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.
Are clinical trials in Greenville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 2 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated March 2, 2026 from ClinicalTrials.gov